Correlation Between Bank Central and Traws Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank Central and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Central Asia and Traws Pharma, you can compare the effects of market volatilities on Bank Central and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and Traws Pharma.

Diversification Opportunities for Bank Central and Traws Pharma

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bank and Traws is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Bank Central i.e., Bank Central and Traws Pharma go up and down completely randomly.

Pair Corralation between Bank Central and Traws Pharma

Assuming the 90 days horizon Bank Central is expected to generate 23.12 times less return on investment than Traws Pharma. But when comparing it to its historical volatility, Bank Central Asia is 8.87 times less risky than Traws Pharma. It trades about 0.01 of its potential returns per unit of risk. Traws Pharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,060  in Traws Pharma on October 22, 2024 and sell it today you would lose (445.00) from holding Traws Pharma or give up 41.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.2%
ValuesDaily Returns

Bank Central Asia  vs.  Traws Pharma

 Performance 
       Timeline  
Bank Central Asia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Traws Pharma 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Traws Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Traws Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Bank Central and Traws Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank Central and Traws Pharma

The main advantage of trading using opposite Bank Central and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.
The idea behind Bank Central Asia and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities